Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 916 M947 M951 M1.06 B918 M 3.88 B Research & development ————— — Operating income 814 M1.47 B1.28 B1.38 B1.22 B 5.34 B Non-Operating Income, Total ————— — Interest expense, net of interest capitalized 207 M197 M186 M167 M154 M 704 M Non-Operating Income, excl. Interest Expenses ————— — Unusual income/expense ————— — Pretax income 687 M1.35 B1.17 B1.29 B1.14 B 4.96 B Equity in earnings -13 M4 M6 M-5 M-6 M -1 M Taxes 104 M291 M262 M284 M229 M 1.07 B Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations 583 M1.06 B912 M1.01 B915 M 3.9 B Discontinued operations ————— — Net income 583 M1.06 B912 M1.01 B915 M 3.9 B Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 583 M1.06 B912 M1.01 B915 M 3.9 B Basic earnings per share (Basic EPS) 5.9210.889.4710.589.81 40.74 Diluted earnings per share (Diluted EPS) 5.8310.739.3310.399.68 40.13 Average basic shares outstanding 98.5 M97.4 M96.3 M96.7 M93.3 M — Diluted shares outstanding 100 M98.8 M97.8 M98.2 M94.5 M — EBITDA 818 M1.47 B1.28 B1.44 B1.22 B 5.41 B EBIT 814 M1.47 B1.28 B1.38 B1.22 B 5.34 B Cost of revenue 515 M355 M488 M434 M462 M 1.74 B Other cost of goods sold ————— — Depreciation & amortization (cash flow) 4 M3 M4 M64 M3 M 74 M